173 related articles for article (PubMed ID: 38750699)
41. Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors.
Ojha T; Pathak V; Shi Y; Hennink WE; Moonen CTW; Storm G; Kiessling F; Lammers T
Adv Drug Deliv Rev; 2017 Sep; 119():44-60. PubMed ID: 28697952
[TBL] [Abstract][Full Text] [Related]
42. Computational model of silica nanoparticle penetration into tumor spheroids: Effects of methoxy and carboxy PEG surface functionalization and hyperthermia.
Nagesetti A; Dulikravich GS; Orlande HRB; Colaco MJ; McGoron AJ
Int J Numer Method Biomed Eng; 2021 Aug; 37(8):e3504. PubMed ID: 34151543
[TBL] [Abstract][Full Text] [Related]
43. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects.
Maeda H
Bioconjug Chem; 2010 May; 21(5):797-802. PubMed ID: 20397686
[TBL] [Abstract][Full Text] [Related]
44. Review of the Delivery Kinetics of Thermosensitive Liposomes.
Haemmerich D; Ramajayam KK; Newton DA
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672347
[TBL] [Abstract][Full Text] [Related]
45. Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting.
Maeda H
Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(3):53-71. PubMed ID: 22450535
[TBL] [Abstract][Full Text] [Related]
46. Approaches to Improve Macromolecule and Nanoparticle Accumulation in the Tumor Microenvironment by the Enhanced Permeability and Retention Effect.
Ejigah V; Owoseni O; Bataille-Backer P; Ogundipe OD; Fisusi FA; Adesina SK
Polymers (Basel); 2022 Jun; 14(13):. PubMed ID: 35808648
[TBL] [Abstract][Full Text] [Related]
47. The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy.
Shi Y; van der Meel R; Chen X; Lammers T
Theranostics; 2020; 10(17):7921-7924. PubMed ID: 32685029
[TBL] [Abstract][Full Text] [Related]
48. Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities.
Kirtane AR; Kalscheuer SM; Panyam J
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1731-47. PubMed ID: 24036273
[TBL] [Abstract][Full Text] [Related]
49. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
[TBL] [Abstract][Full Text] [Related]
50. Simulation of transport and extravasation of nanoparticles in tumors which exhibit enhanced permeability and retention effect.
Podduturi VP; Magaña IB; O'Neal DP; Derosa PA
Comput Methods Programs Biomed; 2013 Oct; 112(1):58-68. PubMed ID: 23871689
[TBL] [Abstract][Full Text] [Related]
51. Magnetic Heating Stimulated Cargo Release with Dose Control using Multifunctional MR and Thermosensitive Liposome.
Ray S; Cheng CA; Chen W; Li Z; Zink JI; Lin YY
Nanotheranostics; 2019; 3(2):166-178. PubMed ID: 31183312
[No Abstract] [Full Text] [Related]
52. Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple-negative breast cancer.
Cao Y; Meng F; Cai T; Gao L; Lee J; Solomevich SO; Aharodnikau UE; Guo T; Lan M; Liu F; Li Q; Viktor T; Li D; Cai Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1950. PubMed ID: 38528388
[TBL] [Abstract][Full Text] [Related]
53. Enhanced permeability and retention effect-focused tumor-targeted nanomedicines: latest trends, obstacles and future perspective.
Shekhar S; Chauhan M; Sonali ; Yadav B; Dutt R; Hu L; Muthu MS; Singh RP
Nanomedicine (Lond); 2022 Aug; 17(18):1213-1216. PubMed ID: 36136592
[No Abstract] [Full Text] [Related]
54. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.
Greish K
J Drug Target; 2007; 15(7-8):457-64. PubMed ID: 17671892
[TBL] [Abstract][Full Text] [Related]
55. A novel targeted multifunctional nanoplatform for visual chemo-hyperthermia synergy therapy on metastatic lymph nodes via lymphatic delivery.
Liu W; Ye X; He L; Cheng J; Luo W; Zheng M; Hu Y; Zhang W; Cao Y; Ran H; Yang L
J Nanobiotechnology; 2021 Dec; 19(1):432. PubMed ID: 34930301
[TBL] [Abstract][Full Text] [Related]
56. Imaging of Nanoparticle Distribution to Assess Treatments That Alter Delivery.
Blocker SJ; Shields AF
Mol Imaging Biol; 2018 Jun; 20(3):340-351. PubMed ID: 29188418
[TBL] [Abstract][Full Text] [Related]
57. Simulation study of the effects of interstitial fluid pressure and blood flow velocity on transvascular transport of nanoparticles in tumor microenvironment.
Gao Y; Shi Y; Fu M; Feng Y; Lin G; Kong D; Jiang B
Comput Methods Programs Biomed; 2020 Sep; 193():105493. PubMed ID: 32408237
[TBL] [Abstract][Full Text] [Related]
58. Stromal disruption facilitating invasion of a 'nano-arsenal' into the solid tumor.
Fu Y; Saraswat AL; Monpara J; Patel K
Drug Discov Today; 2022 Apr; 27(4):1132-1141. PubMed ID: 34823002
[TBL] [Abstract][Full Text] [Related]
59. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
[TBL] [Abstract][Full Text] [Related]
60. Magnetic nanoparticles for amalgamation of magnetic hyperthermia and chemotherapy: An approach towards enhanced attenuation of tumor.
Singh A; Jain S; Sahoo SK
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110695. PubMed ID: 32204010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
